Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01023737
Title Hydroxychloroquine + Vorinostat in Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Devalingam Mahalingam
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Therapy & Research Center University of Texas Health Science Center San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field